Editorial: The Challenge of Defining Alzheimer Disease Based on Biomarkers in the Absence of Symptoms
17 Jul, 2019 | 09:19h | UTCThe Challenge of Defining Alzheimer Disease Based on Biomarkers in the Absence of Symptoms – JAMA Neurology (free for a limited period)
Original Article: Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework – JAMA Neurology (free)
Related Commentary on Twitter
The term "Alzheimer Clinical Syndrome", as opposed to "probable Alzheimer disease", distinguishes the biology from the associated clinical syndrome. https://t.co/9RwdaTEpUR
— JAMA Neurology (@JAMANeuro) July 16, 2019